Benjamin Hohl

CHIEF FINANCIAL OFFICER

CHIEF FINANCIAL OFFICER at Enliven Therapeutics, Inc., filing insider transactions between 2026-03-06 and 2026-06-17.

Total Purchases

—

0 transactions

Total Sales

$559K

4 transactions

Companies Traded

4 total filings

Active Since

2026-03-06

Last: 2026-06-17

Companies

Enliven Therapeutics, Inc.

Date	Ticker	Type	Shares	Price	Value	Owned After
2026-06-17	ELVN	Sale	1,238	$44.75	$55K	51.0K	SEC ↗
2026-06-17	ELVN	Sale	1,379	$42.78	$59K	55.6K	SEC ↗
2026-06-17	ELVN	Sale	3,401	$43.86	$149K	52.2K